Aperya develops a patent-pending ingredient platform designed to significantly enhance topical absorption for skincare products. This solution increases the uptake of key active ingredients by up to 100 times without causing irritation. The platform is formulated to integrate seamlessly into cosmetic, pharmaceutical, and regenerative cream bases.
Funding
Funding not disclosed
Founders
Product
Problem
Topical skincare products often fail to deliver active ingredients effectively because the skin's natural barrier prevents adequate absorption. As a result, a significant portion of these ingredients, estimated at 95%, do not reach their intended target within the skin.
Solution
Aperya has developed a patent-pending ingredient platform designed to significantly enhance the skin's absorption of topical cream ingredients. This technology facilitates a substantial increase in the uptake of active ingredients, reportedly by up to 100 times, enabling deeper penetration and improved efficacy of skincare formulations. The platform is designed to be gentle on the skin, minimizing the risk of irritation while maximizing the delivery of key components in cosmetic, pharmaceutical, and regenerative products. By improving ingredient absorption, Aperya aims to unlock the full potential of topical treatments.
Target Audience
The primary target audience includes skincare formulators, cosmetic companies, and pharmaceutical manufacturers seeking to improve the efficacy of their topical products through enhanced ingredient delivery.
Features
- Proprietary ingredient platform that enhances transdermal delivery
- Demonstrated 100x increase in the uptake of topical cream ingredients
- Gentle formulation suitable for sensitive skin with minimal irritation
- Compatible with a wide range of formulations, including cosmetics, pharmaceuticals, and regenerative medicine
- Patent-pending technology ensuring a unique and protected solution